Annual CFO
-$7.18 M
+$4.69 M+39.52%
01 June 2024
Summary:
Kintara Therapeutics annual cash flow from operations is currently -$7.18 million, with the most recent change of +$4.69 million (+39.52%) on 01 June 2024. During the last 3 years, it has risen by +$11.68 million (+61.95%).KTRA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.44 M
+$858.00 K+37.30%
01 June 2024
Summary:
Kintara Therapeutics quarterly cash flow from operations is currently -$1.44 million, with the most recent change of +$858.00 thousand (+37.30%) on 01 June 2024. Over the past year, it has dropped by -$125.00 thousand (-9.49%).KTRA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$7.18 M
+$66.00 K+0.91%
01 June 2024
Summary:
Kintara Therapeutics TTM cash flow from operations is currently -$7.18 million, with the most recent change of +$66.00 thousand (+0.91%) on 01 June 2024. Over the past year, it has dropped by -$363.00 thousand (-5.33%).KTRA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.5% | -9.5% | -5.3% |
| 3 y3 years | +62.0% | +71.6% | +63.8% |
| 5 y5 years | -13.4% | +36.4% | -10.3% |
KTRA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | <-9999.0% | >+9999.0% |
Kintara Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$7.18 M(-39.5%) | -$1.44 M(-37.3%) | -$7.18 M(-0.9%) |
| Mar 2024 | - | -$2.30 M(+8.6%) | -$7.24 M(+7.0%) |
| Dec 2023 | - | -$2.12 M(+60.7%) | -$6.77 M(-0.6%) |
| Sept 2023 | - | -$1.32 M(-12.7%) | -$6.81 M(-42.6%) |
| June 2023 | -$11.87 M(-41.8%) | -$1.51 M(-17.5%) | -$11.87 M(-22.7%) |
| Mar 2023 | - | -$1.83 M(-15.5%) | -$15.35 M(-18.1%) |
| Dec 2022 | - | -$2.16 M(-66.1%) | -$18.75 M(-13.6%) |
| Sept 2022 | - | -$6.37 M(+27.6%) | -$21.69 M(+6.4%) |
| June 2022 | -$20.39 M(+8.1%) | -$4.99 M(-4.4%) | -$20.39 M(+1.5%) |
| Mar 2022 | - | -$5.22 M(+2.3%) | -$20.09 M(+3.0%) |
| Dec 2021 | - | -$5.10 M(+0.6%) | -$19.50 M(-1.6%) |
| Sept 2021 | - | -$5.07 M(+8.2%) | -$19.82 M(+5.1%) |
| June 2021 | -$18.86 M(+137.9%) | -$4.69 M(+1.3%) | -$18.86 M(+12.6%) |
| Mar 2021 | - | -$4.63 M(-14.7%) | -$16.75 M(+24.1%) |
| Dec 2020 | - | -$5.43 M(+32.1%) | -$13.49 M(+38.1%) |
| Sept 2020 | - | -$4.11 M(+59.4%) | -$9.77 M(+23.3%) |
| June 2020 | -$7.93 M(+25.3%) | -$2.58 M(+87.8%) | -$7.93 M(+10.7%) |
| Mar 2020 | - | -$1.37 M(-19.8%) | -$7.16 M(-1.3%) |
| Dec 2019 | - | -$1.71 M(-24.5%) | -$7.25 M(+11.5%) |
| Sept 2019 | - | -$2.27 M(+25.0%) | -$6.51 M(+2.9%) |
| June 2019 | -$6.33 M(-35.8%) | -$1.81 M(+23.8%) | -$6.33 M(-10.2%) |
| Mar 2019 | - | -$1.46 M(+51.8%) | -$7.05 M(-16.1%) |
| Dec 2018 | - | -$965.00 K(-53.7%) | -$8.40 M(-12.2%) |
| Sept 2018 | - | -$2.08 M(-17.7%) | -$9.56 M(-2.9%) |
| June 2018 | -$9.85 M(+22.8%) | -$2.53 M(-9.9%) | -$9.85 M(-8.5%) |
| Mar 2018 | - | -$2.81 M(+31.9%) | -$10.77 M(+13.8%) |
| Dec 2017 | - | -$2.13 M(-10.1%) | -$9.46 M(+7.8%) |
| Sept 2017 | - | -$2.37 M(-31.2%) | -$8.78 M(+9.5%) |
| June 2017 | -$8.02 M | -$3.45 M(+128.8%) | -$8.02 M(+31.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$1.51 M(+4.0%) | -$6.12 M(+9.9%) |
| Dec 2016 | - | -$1.45 M(-10.2%) | -$5.57 M(+4.0%) |
| Sept 2016 | - | -$1.61 M(+3.8%) | -$5.36 M(+4.1%) |
| June 2016 | -$5.15 M(+33.5%) | -$1.55 M(+62.4%) | -$5.15 M(+16.9%) |
| Mar 2016 | - | -$956.90 K(-22.4%) | -$4.40 M(-0.5%) |
| Dec 2015 | - | -$1.23 M(-12.0%) | -$4.42 M(+3.3%) |
| Sept 2015 | - | -$1.40 M(+73.4%) | -$4.28 M(+11.2%) |
| June 2015 | -$3.85 M(+107.4%) | -$808.60 K(-17.4%) | -$3.85 M(+26.6%) |
| Mar 2015 | - | -$979.10 K(-10.5%) | -$3.04 M(+3.2%) |
| Dec 2014 | - | -$1.09 M(+12.6%) | -$2.95 M(+2.1%) |
| Sept 2014 | - | -$971.50 K(+9.8%) | -$2.89 M(-32.5%) |
| June 2014 | -$1.86 M(-66.3%) | - | - |
| Mar 2014 | - | -$884.50 K(-14.5%) | -$4.28 M(-22.5%) |
| Dec 2013 | -$5.52 M(>+9900.0%) | -$1.03 M(-7.0%) | -$5.52 M(+23.0%) |
| Sept 2013 | - | -$1.11 M(-11.0%) | -$4.49 M(+32.8%) |
| June 2013 | - | -$1.25 M(-41.2%) | -$3.38 M(+58.6%) |
| Mar 2013 | - | -$2.12 M(>+9900.0%) | -$2.13 M(>+9900.0%) |
| Dec 2012 | - | -$1600.00(-61.9%) | -$9900.00(-40.7%) |
| Sept 2012 | - | -$4200.00(+320.0%) | -$16.70 K(+46.5%) |
| June 2012 | - | -$1000.00(-67.7%) | -$11.40 K(-48.6%) |
| June 2012 | -$11.40 K(-70.6%) | - | - |
| Mar 2012 | - | -$3100.00(-63.1%) | -$22.20 K(-3.1%) |
| Dec 2011 | - | -$8400.00(-863.6%) | -$22.90 K(-21.3%) |
| Sept 2011 | - | $1100.00(-109.3%) | -$29.10 K(-25.0%) |
| June 2011 | -$38.80 K(+691.8%) | -$11.80 K(+210.5%) | -$38.80 K(+43.7%) |
| Mar 2011 | - | -$3800.00(-74.0%) | -$27.00 K(+16.4%) |
| Dec 2010 | - | -$14.60 K(+69.8%) | -$23.20 K(+169.8%) |
| Sept 2010 | - | -$8600.00 | -$8600.00 |
| June 2010 | -$4900.00 | - | - |
FAQ
- What is Kintara Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Kintara Therapeutics?
- What is Kintara Therapeutics annual CFO year-on-year change?
- What is Kintara Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly CFO year-on-year change?
- What is Kintara Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Kintara Therapeutics?
- What is Kintara Therapeutics TTM CFO year-on-year change?
What is Kintara Therapeutics annual cash flow from operations?
The current annual CFO of KTRA is -$7.18 M
What is the all time high annual CFO for Kintara Therapeutics?
Kintara Therapeutics all-time high annual cash flow from operations is -$4900.00
What is Kintara Therapeutics annual CFO year-on-year change?
Over the past year, KTRA annual cash flow from operations has changed by +$4.69 M (+39.52%)
What is Kintara Therapeutics quarterly cash flow from operations?
The current quarterly CFO of KTRA is -$1.44 M
What is the all time high quarterly CFO for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly cash flow from operations is $1100.00
What is Kintara Therapeutics quarterly CFO year-on-year change?
Over the past year, KTRA quarterly cash flow from operations has changed by -$125.00 K (-9.49%)
What is Kintara Therapeutics TTM cash flow from operations?
The current TTM CFO of KTRA is -$7.18 M
What is the all time high TTM CFO for Kintara Therapeutics?
Kintara Therapeutics all-time high TTM cash flow from operations is -$8600.00
What is Kintara Therapeutics TTM CFO year-on-year change?
Over the past year, KTRA TTM cash flow from operations has changed by -$363.00 K (-5.33%)